within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M03A_MuscleRelaxantsPeripherallyActingAgents.M03AA02_Tubocurarine;

model Tubocurarine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.5166666666666668e-06,
    adminDuration = 600,
    adminMass = 25 / 1000000,
    adminCount = 1,
    Vd = 8.999999999999999e-05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.00022,
    k12 = 0.00028,
    k21 = 0.00028);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Tubocurarine</td></tr><tr><td>ATC code:</td><td>M03AA02</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>25</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.09</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.3</td><td>mL/kg/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Tubocurarine is a non-depolarizing skeletal muscle relaxant, historically used adjunctively in anesthesia to produce muscle relaxation during surgery or mechanical ventilation. It acts by blocking nicotinic acetylcholine receptors at the neuromuscular junction. Its use has largely been discontinued due to side effects and the development of newer, safer alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult surgical patients, following intravenous administration.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.M.M03AA02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Tubocurarine;
